Cytogen, Inc. (KOSDAQ:217330)
4,640.00
-235.00 (-4.82%)
At close: Mar 6, 2026
1.31% (1Y)
| Market Cap | 107.04B |
| Revenue (ttm) | 25.09B |
| Net Income (ttm) | -15.23B |
| Shares Out | 23.07M |
| EPS (ttm) | -660.60 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 315,232 |
| Average Volume | 432,090 |
| Open | 4,875.00 |
| Previous Close | 4,875.00 |
| Day's Range | 4,455.00 - 4,880.00 |
| 52-Week Range | 2,260.00 - 11,200.00 |
| Beta | -0.27 |
| RSI | 28.11 |
| Earnings Date | Nov 21, 2025 |